The global pleural catheters market is experiencing significant growth due to the increasing prevalence of pleural effusion and the rising demand for minimally invasive procedures. Pleural effusion, characterized by the accumulation of fluid in the pleural cavity surrounding the lungs, can cause respiratory distress and other complications. Pleural catheters, also known as chest tubes or thoracostomy tubes, are used for the drainage of excess fluid or air from the pleural space. These catheters are inserted through a small incision in the chest wall, enabling efficient and controlled drainage. The growing geriatric population, who are more susceptible to pleural effusion, along with the rising incidence of respiratory diseases, such as pneumonia and lung cancer, are driving the demand for pleural catheters worldwide.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=3128
Segmentation of Pleural Catheters Industry Research
-
By Indication :
- Malignant Pleural Effusions
- Non-Malignant Recurrent Effusions
- Chylothorax
- Empyema
- Haemothorax
-
By End User :
- Hospitals
- Ambulatory Surgical Centers
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Get Customization on this Report for Specific Research Solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=3128
Pleural Catheters Market - Key Takeaways
- Malignant pleural effusion will remain the top indication type, with three-quarters of revenue share, owing to frequent utilization of clinical management of both malignant and benign effusion.
- Owing to the availability of pleural catheters and skilled personnel for better clinical management of patients, hospitals account for 2/3rd of overall market value.
- Developed regional markets collectively account for more than 60%, on the back of rising elderly population and increase in accessibility to healthcare facilities.
- An increase in the prevalence of COPD and the expansion of private hospitals in rural areas are boosting the demand for pleural catheters in Asia Pacific.
Competitive Landscape
Prominent pleural catheter manufacturers are Rocket Medical plc., Merit Medical Systems, Inc., Becton, Dickinson and Company, B. Braun Melsungen, and Eakin Healthcare Group.
Rising prevalence of chronic diseases is the major factor that is driving manufacturers to develop pleural catheter products. Key suppliers of pleural catheter products are incorporating innovative technologies and optimization systems in their product lines according to end usability.
- In Dec 2020, Eakin Healthcare Group acquired Armstrong Medical, a firm that makes respiratory products, to expand its product line into a new therapeutic area.
Key Companies Profiled
- Rocket Medical plc.
- Merit Medical Systems, Inc.
- BD
- B. Braun Melsungen
- Eakin Healthcare Group
Country-wise Insights
The pleural catheters market exhibits significant variations and opportunities across different countries. In North America, the United States dominates the market due to factors such as a well-established healthcare infrastructure, high healthcare expenditure, and a large patient population suffering from respiratory diseases. The presence of key market players and ongoing technological advancements in the region further contribute to its market leadership. In Europe, countries like Germany, the United Kingdom, and France are prominent markets for pleural catheters, driven by a high prevalence of respiratory conditions and a growing geriatric population. The increasing adoption of minimally invasive procedures and favorable reimbursement policies also support market growth in these regions. In the Asia Pacific, countries such as China, Japan, and India are witnessing rapid market expansion due to a rising burden of respiratory diseases, improving healthcare infrastructure, and increasing awareness about minimally invasive treatment options. The market in Latin America and the Middle East & Africa is expected to experience steady growth, fueled by improving healthcare access, growing healthcare expenditure, and a rising incidence of respiratory conditions.
For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/3128
